The National Agency for Food and Drug Administration and Control has raised the alarm over the circulation of suspected counterfeit Colgate toothpaste products, warning of potential health risks to consumers.
In a public notice issued on Sunday, April 20, the agency disclosed that its Post-Marketing Surveillance Directorate received a complaint regarding the distribution of unregistered toothpaste, prompting immediate action.
Following the report, NAFDAC officials inspected a retail outlet in Kaduna where the products were found on sale. During the visit, two suspicious items branded as “Coglaet ActivGel 100g” and “Coglaet Herbal 100g” were discovered.
“The shop owner informed the team that the products were purchased from a door-to-door sales representative; however, no proof of purchase was provided,” the agency said.
“These products have not met the required regulatory standards for registration and quality assurance, thereby posing a potential risk to public health and safety,” the agency added.
NAFDAC confirmed that the items have since been removed from circulation while investigations continue to identify the sources and distribution channels of the counterfeit goods.
READ ALSO: NAFDAC Raises Alarm Over Fake Cancer Drug
Further checks revealed that the affected products, including “Coglaet Crema Dental Herbal 100g” and “Coglaet ActivGel 100g,” lacked batch numbers and NAFDAC registration details, raising concerns about their authenticity.
The products were labelled as being manufactured by Guangzhou YECAI Oral Cleaning Products Co., Ltd, based in Baiyun District, Guangzhou, China, with manufacturing dates listed as August 2025 and expiry dates in August 2029.
As part of its response, the agency has directed all zonal directors and state coordinators to intensify surveillance efforts and remove the counterfeit products wherever they are found.
NAFDAC also urged distributors, retailers, and consumers to remain vigilant by verifying product authenticity and physical condition before purchase or use.
Members of the public were advised to report suspected counterfeit or substandard products to the nearest NAFDAC office, call 0800-162-3322, or send complaints via email to sf.alert@nafdac.gov.ng.
Healthcare professionals and patients were further encouraged to report any adverse reactions linked to such products through official reporting channels, including the agency’s website and the Med-Safety mobile application.
